Rakesh Baboo, MD
Internal Medicine · Stockton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 17 years
- Graduated 2009
Offices
1 location · Dignity Health Medical Foundation · 1,211 clinicians in this group
Looking this up.
Hospitals listed: 057212 · 059401 · 559446 · Adventist Health Lodi Memorial · St Joseph'S Medical Center of Stockton. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Baboo’s office at (209) 475-5500 to ask if they take your plan before you enroll.
California Medical Board record
Licence A173931 · Current
Licensed to practise in California · since 2021 · expires 2027-07-31 · Dow University of Health Sciences, Sindh Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 96.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health Lodi MemorialLodi, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.222, Oct 2024 – Sep 2025
- St Joseph'S Medical Center of StocktonStockton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 67% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.08, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.34, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Lodi Memorial
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 6 the same, 0 worse of 6 measures. Readmissions: 1 better, 3 the same, 2 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.222 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.16 to 2.22) · 678 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.59 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 203.28 (143.15 to 263.4) · 29 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 43 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 334 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 570 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.9 · 184 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 1,823 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.02 to 0.45) · 4,072 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.08 to 0.49) · 4,094 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.18 (0.83 to 5.53) · 476 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.34) · 81 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.8 to 4.13) · 448 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.29 (0 to 17.86) · 79 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 78 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.16) · 142 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.74 (0 to 1.53) · 3,347 cases | No different | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.368 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.655 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.506 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 27 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 450 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 47.3 · 381 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.2 · 604 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20.1 · 661 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.9 · 188 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.6 (8.9 to 15.2) · 932 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 449 cases | No different | Jan 2024 – Dec 2024 |
What patients said (438 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 79% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for St Joseph'S Medical Center of Stockton
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.08 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.34 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.51 (0.54 to 2.47) · 1,424 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.78 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.22 (98.08 to 180.36) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 127 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 98 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.9 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.2 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.4 · 405 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9 · 337 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,812 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.09 to 0.49) · 6,528 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,304 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.48 (1.49 to 5.48) · 1,467 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.27 (0 to 2.79) · 464 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.22 (0.81 to 3.64) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.16 (1.3 to 13.02) · 455 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.22 (1.5 to 8.93) · 456 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.24 (0.78 to 3.71) · 262 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.03 (0.53 to 1.53) · 6,521 cases | No different | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.537 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.486 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.646 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 484 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 878 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.2 · 265 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 17.1 · 493 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 407 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 615 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 14.1 · 184 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.6) · 164 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 290 cases | No different | Jan 2024 – Dec 2024 |
What patients said (541 patients answered, 14% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$100,140
Medicare paid this office $100,140 for 253 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 166 | $30,359 | $94 |
| Long return visit (40+ min) | 120 | $28,849 | $128 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 84 | $11,793 | $140 |
| Short return visit (20+ min) | 69 | $5,411 | $65 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 18 | $5,193 | $289 |
See all 15 services
| Return visit (30+ min) | 166 | $30,359 | $94 |
| Long return visit (40+ min) | 120 | $28,849 | $128 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 84 | $11,793 | $140 |
| Short return visit (20+ min) | 69 | $5,411 | $65 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 18 | $5,193 | $289 |
| Advance care planning, first 30 minutes | 55 | $4,595 | $84 |
| New patient visit (45+ min) | 16 | $1,967 | $123 |
| Influenza vaccine, inactivated | 22 | $1,800 | $82 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 48 | $1,026 | $14 |
| Administration of influenza virus vaccine | 25 | $845 | $33 |
| Administration of pneumococcal vaccine | 18 | $592 | $33 |
| Face-to-face behavioral counseling for obesity, 15 minutes | 16 | $541 | $27 |
| Smoking and tobacco use intensive counseling, more than 10 minutes | 12 | $406 | $29 |
| Hemoglobin a1c level | 22 | $238 | $10 |
| Assessment of emotional or behavioral problems | 15 | $53 | $3 |
Who their Medicare patients are
253 Original Medicare patients in 2024. Average age 71 · Under 65 19% · 85 and older 12% · Women 56% · Also on Medicaid 44% · Health risk score 1.53. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 43% · Chronic kidney disease 37% · Coronary heart disease 28% · Depression 21% · Heart failure 17% · COPD 15% · Atrial fibrillation 14% · Dementia 11% · Cancer 10% · Stroke 9%.
The office billed $375,554, Medicare allowed $132,396 and paid $100,140; for 1,199 services of 53 kinds; $7,244 of it was for drugs given in the office and $92,896 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 253 | 1,199 | 71 | 1.53 | $375,554 | $100,140 |
| 2023 | 234 | 944 | 71 | 1.58 | $295,588 | $79,611 |
| 2022 | 226 | 599 | 71 | 1.29 | $154,080 | $41,806 |
| 2021 | 59 | 125 | 71 | 1.39 | $24,985 | $7,754 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Long return visit (40+ min) | 117 | $26,185 | $136 |
| Return visit (30+ min) | 117 | $14,723 | $90 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 29 | $8,151 | $281 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 44 | $7,562 | $172 |
| Short return visit (20+ min) | 73 | $5,303 | $58 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 29 | $3,915 | $135 |
| New patient visit (60+ min) | 20 | $3,241 | $162 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 36 | $2,783 | $75 |
| New patient visit (45+ min) | 19 | $1,652 | $87 |
| Administration of influenza virus vaccine | 44 | $1,354 | $30 |
| Administration of pneumococcal vaccine | 29 | $932 | $32 |
| Short return visit | 13 | $663 | $41 |
| Injection of drug or substance under skin or into muscle | 14 | $167 | $9 |
| Hemoglobin a1c level | 15 | $152 | $10 |
2022: 12 services
| Return visit (30+ min) | 98 | $12,892 | $93 |
| Short return visit (20+ min) | 109 | $8,161 | $58 |
| New patient visit (45+ min) | 43 | $4,059 | $94 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 11 | $3,061 | $278 |
| New patient visit (60+ min) | 12 | $2,166 | $180 |
| Long return visit (40+ min) | 15 | $2,096 | $140 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,483 | $135 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 21 | $1,468 | $70 |
| Short return visit | 26 | $863 | $33 |
| Administration of influenza virus vaccine | 26 | $767 | $29 |
| Administration of pneumococcal vaccine | 13 | $401 | $31 |
| Hemoglobin a1c level | 18 | $172 | $10 |
2021: 4 services
| Return visit (30+ min) | 26 | $2,291 | $88 |
| Short return visit (20+ min) | 23 | $1,750 | $76 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 13 | $797 | $61 |
| Administration of influenza virus vaccine | 14 | $232 | $17 |
Medicaid work
$13,867 in 2024
Medicaid paid $13,867 for 1,182 billed services this clinician did in 2024, up to 63 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 625 | $10,212 |
| Long return visit (40+ min) | 307 | $1,896 |
| Short return visit (20+ min) | 203 | $939 |
| New patient visit (30+ min) | 12 | $335 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 16 | $315 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 19 | $171 |
| 2024 | 1,182 | 6 | 63 | $13,867 |
| 2023 | 1,527 | 5 | 89 | $6,713 |
| 2022 | 1,338 | 7 | 81 | $3,453 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 404 | $2,743 |
| Return visit (30+ min) | 507 | $1,777 |
| Short return visit (20+ min) | 554 | $1,233 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 30 | $615 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 32 | $345 |
2022
| New patient visit (45+ min) | 214 | $1,026 |
| Short return visit (20+ min) | 551 | $962 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 32 | $682 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 50 | $468 |
| Return visit (30+ min) | 371 | $203 |
| New patient visit (30+ min) | 12 | $69 |
| Short return visit | 108 | $43 |
Drugs they prescribed that Part D paid
$473,789
Pharmacies billed $473,789 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (52 of 5,800) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
5,099 generic and 645 brand-name prescriptions · $473,789 in drug cost · 135 antibiotic prescriptions to 89 people · 20 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 79 | $82,838 | $1,049 |
| Ozempic | 39 | $46,547 | $1,194 |
| Eliquis | 26 | $26,870 | $1,033 |
| Xarelto | 28 | $23,515 | $840 |
| Trelegy Ellipta | 21 | $12,946 | $616 |
See all 94 drugs
| Jardiance | 79 | $82,838 | $1,049 |
| Ozempic | 39 | $46,547 | $1,194 |
| Eliquis | 26 | $26,870 | $1,033 |
| Xarelto | 28 | $23,515 | $840 |
| Trelegy Ellipta | 21 | $12,946 | $616 |
| Mounjaro | 12 | $12,120 | $1,010 |
| Linzess | 17 | $11,389 | $670 |
| Entresto | 13 | $9,180 | $706 |
| Symbicort | 17 | $5,194 | $306 |
| Atorvastatin | 445 | $4,813 | $11 |
| Pregabalin | 27 | $3,474 | $129 |
| Fluticasone Propionate | 100 | $3,306 | $33 |
| Basaglar Kwikpen U-100 | 12 | $3,261 | $272 |
| Albuterol Sulfate Hfa | 118 | $3,212 | $27 |
| Levothyroxine | 203 | $2,962 | $15 |
| Budesonide-Formoterol | 12 | $2,437 | $203 |
| Losartan | 231 | $2,404 | $10 |
| Mirtazapine | 51 | $2,358 | $46 |
| Gabapentin | 205 | $2,278 | $11 |
| Rosuvastatin | 80 | $2,204 | $28 |
| Pantoprazole | 147 | $1,965 | $13 |
| Metoprolol | 75 | $1,904 | $25 |
| Lidocaine | 25 | $1,875 | $75 |
| Omeprazole | 128 | $1,785 | $14 |
| Metoprolol | 84 | $1,679 | $20 |
| Nifedipine Er | 48 | $1,621 | $34 |
| Lantus Solostar | 16 | $1,486 | $93 |
| Amlodipine Besylate | 223 | $1,353 | $6 |
| Lisinopril | 139 | $1,094 | $8 |
| Tamsulosin | 99 | $1,051 | $11 |
| Potassium Chloride | 62 | $986 | $16 |
| Famotidine | 72 | $972 | $13 |
| Nano 2nd Gen Pen Needle | 15 | $820 | $55 |
| Montelukast | 47 | $807 | $17 |
| Metformin | 75 | $798 | $11 |
| Baclofen | 77 | $757 | $10 |
| Memantine | 18 | $726 | $40 |
| Allopurinol | 65 | $708 | $11 |
| Duloxetine | 40 | $698 | $17 |
| Venlafaxine Hcl Er | 37 | $690 | $19 |
| Escitalopram | 83 | $656 | $8 |
| Pravastatin | 33 | $652 | $20 |
| Clopidogrel | 31 | $618 | $20 |
| Alendronate | 96 | $599 | $6 |
| Glipizide | 38 | $588 | $15 |
| Carvedilol | 43 | $573 | $13 |
| Furosemide | 91 | $573 | $6 |
| Metformin Hcl Er | 84 | $570 | $7 |
| Simvastatin | 66 | $554 | $8 |
| Glipizide Er | 53 | $533 | $10 |
| Losartan-Hydrochlorothiazide | 29 | $500 | $17 |
| Levetiracetam | 22 | $460 | $21 |
| Diclofenac | 24 | $456 | $19 |
| Oxybutynin Chloride Er | 22 | $456 | $21 |
| Sumatriptan | 24 | $393 | $16 |
| Clobetasol Propionate | 47 | $385 | $8 |
| Quetiapine | 14 | $376 | $27 |
| Omega-3 Acid Ethyl Esters | 14 | $346 | $25 |
| Ibuprofen | 39 | $338 | $9 |
| Hydralazine | 29 | $324 | $11 |
| Trazodone | 70 | $308 | $4 |
| Clotrimazole-Betamethasone | 15 | $302 | $20 |
| Olmesartan Medoxomil | 14 | $288 | $21 |
| Donepezil | 29 | $288 | $10 |
| Hydrocodone-Acetaminophen | 24 | $276 | $12 |
| Amoxicillin-Clavulanate Potass | 18 | $255 | $14 |
| Sertraline | 23 | $240 | $10 |
| Nitrofurantoin Mono-Macro | 11 | $233 | $21 |
| Topiramate | 22 | $231 | $11 |
| Ketoconazole | 12 | $225 | $19 |
| Terazosin | 12 | $222 | $18 |
| Cyclobenzaprine | 35 | $218 | $6 |
| Enalapril Maleate | 13 | $217 | $17 |
| Hydroxychloroquine Sulfate | 11 | $214 | $19 |
| Bupropion Xl | 15 | $210 | $14 |
| Atenolol | 30 | $209 | $7 |
| Doxycycline Hyclate | 26 | $194 | $7 |
| Benazepril | 23 | $189 | $8 |
| Hydroxyzine | 31 | $188 | $6 |
| Finasteride | 19 | $184 | $10 |
| Hydrochlorothiazide | 46 | $147 | $3 |
| Meloxicam | 40 | $142 | $4 |
| Meclizine | 23 | $141 | $6 |
| Zolpidem | 26 | $140 | $5 |
| Dicyclomine | 14 | $131 | $9 |
| Cephalexin | 23 | $129 | $6 |
| Amitriptyline | 11 | $105 | $10 |
| Azithromycin | 29 | $104 | $4 |
| Clonidine | 13 | $74 | $6 |
| Propranolol | 16 | $65 | $4 |
| Alprazolam | 24 | $52 | $2 |
| Tramadol | 21 | $45 | $2 |
| Lorazepam | 11 | $18 | $2 |
| Prednisone | 12 | $15 | $1 |
Year by year
| 2024 | 5,800 | 410 | 1% (52) | 11% | $473,789 |
| 2023 | 5,225 | 470 | 2% (90) | 13% | $464,788 |
| 2022 | 1,854 | 348 | 1% (23) | None | $168,711 |
| 2021 | 158 | 69 | None | 11% | $17,010 |
| 2020 | 423 | 51 | 0% (0) | 34% | $72,415 |
| 2019 | 522 | 81 | 0% (0) | 28% | $62,319 |
| 2018 | 92 | 14 | 0% (0) | None | $2,362 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 97 drugs
| Jardiance | 76 | $64,831 | $853 |
| Trulicity | 30 | $32,286 | $1,076 |
| Xarelto | 25 | $24,785 | $991 |
| Eliquis | 32 | $23,366 | $730 |
| Symbicort | 38 | $19,861 | $523 |
| Januvia | 17 | $16,724 | $984 |
| Lantus Solostar | 15 | $7,129 | $475 |
| Atorvastatin | 400 | $7,065 | $18 |
| Invokana | 12 | $6,983 | $582 |
| Flovent Diskus | 17 | $5,541 | $326 |
| Basaglar Kwikpen U-100 | 15 | $5,288 | $353 |
| Albuterol Sulfate Hfa | 123 | $4,122 | $34 |
| Losartan | 195 | $3,310 | $17 |
| Levothyroxine | 190 | $2,946 | $16 |
| Gabapentin | 153 | $2,429 | $16 |
| Duloxetine | 58 | $1,987 | $34 |
| Memantine | 44 | $1,978 | $45 |
| Pantoprazole | 110 | $1,921 | $17 |
| Novolin N | 11 | $1,909 | $174 |
| Lisinopril | 148 | $1,907 | $13 |
| Metoprolol | 57 | $1,866 | $33 |
| Rosuvastatin | 51 | $1,811 | $36 |
| Tamsulosin | 71 | $1,762 | $25 |
| Metoprolol | 65 | $1,719 | $26 |
| Mirtazapine | 53 | $1,645 | $31 |
| Fluticasone Propionate | 70 | $1,587 | $23 |
| Amlodipine Besylate | 167 | $1,554 | $9 |
| Trazodone | 70 | $1,381 | $20 |
| Nano 2nd Gen Pen Needle | 17 | $1,306 | $77 |
| Pregabalin | 18 | $1,245 | $69 |
| Omeprazole | 104 | $1,174 | $11 |
| Potassium Chloride | 47 | $1,169 | $25 |
| Levetiracetam | 14 | $1,130 | $81 |
| Metformin | 84 | $1,126 | $13 |
| Nifedipine Er | 26 | $1,090 | $42 |
| Allopurinol | 70 | $1,080 | $15 |
| Famotidine | 70 | $1,046 | $15 |
| Buspirone | 11 | $963 | $88 |
| Simvastatin | 58 | $916 | $16 |
| Ventolin Hfa | 14 | $869 | $62 |
| Diclofenac | 40 | $854 | $21 |
| Baclofen | 42 | $831 | $20 |
| Doxycycline Hyclate | 23 | $815 | $35 |
| Furosemide | 85 | $801 | $9 |
| Venlafaxine Hcl Er | 41 | $791 | $19 |
| Cyclobenzaprine | 41 | $786 | $19 |
| Clopidogrel | 30 | $754 | $25 |
| Losartan-Hydrochlorothiazide | 30 | $748 | $25 |
| Metformin Hcl Er | 57 | $731 | $13 |
| Hydrocodone-Acetaminophen | 56 | $702 | $13 |
| Alendronate | 47 | $660 | $14 |
| Montelukast | 50 | $657 | $13 |
| Hydroxyzine | 22 | $615 | $28 |
| Clobetasol Propionate | 44 | $610 | $14 |
| Escitalopram | 31 | $600 | $19 |
| Donepezil | 23 | $598 | $26 |
| Glipizide Er | 51 | $594 | $12 |
| Quetiapine | 17 | $543 | $32 |
| Pravastatin | 22 | $536 | $24 |
| Nitrofurantoin Mono-Macro | 31 | $525 | $17 |
| Clotrimazole-Betamethasone | 13 | $483 | $37 |
| Ibuprofen | 38 | $466 | $12 |
| Oxybutynin Chloride Er | 14 | $440 | $31 |
| Sertraline | 42 | $410 | $10 |
| Synthroid | 14 | $398 | $28 |
| Amoxicillin-Clavulanate Potass | 33 | $387 | $12 |
| Carvedilol | 39 | $366 | $9 |
| Ondansetron | 18 | $355 | $20 |
| Atenolol | 35 | $335 | $10 |
| Valacyclovir | 12 | $291 | $24 |
| Topiramate | 22 | $258 | $12 |
| Glimepiride | 13 | $251 | $19 |
| Azithromycin | 40 | $237 | $6 |
| Hydralazine | 19 | $232 | $12 |
| Tizanidine | 11 | $225 | $20 |
| Hydrochlorothiazide | 49 | $221 | $5 |
| Citalopram Hbr | 12 | $219 | $18 |
| Glipizide | 26 | $217 | $8 |
| Paxlovid (Eua) | 19 | $199 | $10 |
| Sumatriptan | 12 | $193 | $16 |
| Vitamin D2 | 20 | $187 | $9 |
| Venlafaxine | 11 | $183 | $17 |
| Dicyclomine | 11 | $174 | $16 |
| Meclizine | 20 | $171 | $9 |
| Fluconazole | 13 | $171 | $13 |
| Benazepril | 19 | $163 | $9 |
| Finasteride | 11 | $151 | $14 |
| Zolpidem | 17 | $140 | $8 |
| Risperidone | 18 | $130 | $7 |
| Triamterene-Hydrochlorothiazid | 12 | $76 | $6 |
| Meloxicam | 20 | $74 | $4 |
| Prednisone | 28 | $71 | $3 |
| Cephalexin | 14 | $64 | $5 |
| Tramadol | 24 | $62 | $3 |
| Alprazolam | 29 | $56 | $2 |
| Lorazepam | 13 | $54 | $4 |
| Sulfamethoxazole-Trimethoprim | 11 | $35 | $3 |
2022: 52 drugs
| Jardiance | 25 | $21,119 | $845 |
| Trulicity | 15 | $14,344 | $956 |
| Januvia | 15 | $10,206 | $680 |
| Levemir Flextouch | 13 | $8,408 | $647 |
| Symbicort | 21 | $8,229 | $392 |
| Basaglar Kwikpen U-100 | 16 | $7,048 | $441 |
| Atorvastatin | 127 | $1,586 | $12 |
| Albuterol Sulfate Hfa | 39 | $1,542 | $40 |
| Losartan | 85 | $1,200 | $14 |
| Diclofenac | 44 | $935 | $21 |
| Gabapentin | 72 | $812 | $11 |
| Levothyroxine | 46 | $698 | $15 |
| Ofloxacin | 11 | $681 | $62 |
| Ventolin Hfa | 11 | $680 | $62 |
| Tamsulosin | 28 | $657 | $23 |
| Rosuvastatin | 20 | $615 | $31 |
| Lactulose | 12 | $524 | $44 |
| Potassium Chloride | 18 | $509 | $28 |
| Baclofen | 12 | $505 | $42 |
| Metoprolol | 22 | $478 | $22 |
| Nitrofurantoin Mono-Macro | 18 | $403 | $22 |
| Fluticasone Propionate | 31 | $360 | $12 |
| Lisinopril | 47 | $349 | $7 |
| Omeprazole | 33 | $333 | $10 |
| Amlodipine Besylate | 71 | $321 | $5 |
| Pantoprazole | 27 | $288 | $11 |
| Trazodone | 29 | $283 | $10 |
| Cyclobenzaprine | 14 | $282 | $20 |
| Amoxicillin-Clavulanate Potass | 27 | $278 | $10 |
| Duloxetine | 11 | $276 | $25 |
| Metformin | 37 | $266 | $7 |
| Famotidine | 30 | $225 | $8 |
| Allopurinol | 17 | $199 | $12 |
| Montelukast | 20 | $198 | $10 |
| Digoxin | 11 | $175 | $16 |
| Simvastatin | 19 | $168 | $9 |
| Donepezil | 13 | $166 | $13 |
| Atenolol | 19 | $153 | $8 |
| Sertraline | 19 | $149 | $8 |
| Azithromycin | 20 | $130 | $7 |
| Hydroxyzine | 11 | $127 | $12 |
| Triamterene-Hydrochlorothiazid | 11 | $114 | $10 |
| Escitalopram | 11 | $109 | $10 |
| Hydrocodone-Acetaminophen | 16 | $101 | $6 |
| Hydrochlorothiazide | 32 | $96 | $3 |
| Cephalexin | 13 | $86 | $7 |
| Ibuprofen | 13 | $85 | $7 |
| Clobetasol Propionate | 14 | $84 | $6 |
| Furosemide | 19 | $81 | $4 |
| Alendronate | 16 | $77 | $5 |
| Glipizide | 15 | $51 | $3 |
| Lorazepam | 12 | $33 | $3 |
2021: 2 drugs
| Atorvastatin | 12 | $254 | $21 |
| Losartan | 11 | $154 | $14 |
2020: 6 drugs
| Symbicort | 20 | $9,390 | $469 |
| Albuterol Sulfate Hfa | 29 | $1,834 | $63 |
| Ventolin Hfa | 13 | $838 | $64 |
| Nifedipine Er | 13 | $523 | $40 |
| Atorvastatin | 26 | $230 | $9 |
| Timolol Maleate | 11 | $39 | $4 |
2019: 17 drugs
| Symbicort | 18 | $5,927 | $329 |
| Albuterol Sulfate Hfa | 34 | $1,943 | $57 |
| Ventolin Hfa | 13 | $1,069 | $82 |
| Atorvastatin | 38 | $602 | $16 |
| Alcohol Prep Pads | 11 | $599 | $54 |
| Diclofenac | 15 | $515 | $34 |
| Methotrexate | 11 | $420 | $38 |
| Nifedipine Er | 14 | $330 | $24 |
| Metoprolol | 15 | $316 | $21 |
| Enalapril Maleate | 13 | $243 | $19 |
| Cilostazol | 16 | $224 | $14 |
| Clopidogrel | 11 | $97 | $9 |
| Gabapentin | 14 | $94 | $7 |
| Metformin | 15 | $71 | $5 |
| Amlodipine Besylate | 17 | $60 | $4 |
| Famotidine | 14 | $48 | $3 |
| Lisinopril | 11 | $34 | $3 |
2018: 1 drug
| Polyethylene Glycol 3350 | 13 | $155 | $12 |
Professional record
- NPI
- 1083190839
- Licence
- CA A173931California A173931: Current · expires 2027-07-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 3400 Data Dr, Rancho Cordova, CA, 95670
- NPI first listed
- 2018-07-16
- NPI last updated
- 2021-09-30
- NPI record certified
- 2021-09-30
This is when the NPI record was last certified, not a medical board exam.